Montrusco Bolton Investments Inc. Has $76.86 Million Holdings in Zoetis Inc. $ZTS

Montrusco Bolton Investments Inc. cut its stake in shares of Zoetis Inc. (NYSE:ZTS) by 17.2% in the second quarter, Holdings Channel reports. The firm owned 492,852 shares of the company’s stock after selling 102,497 shares during the quarter. Zoetis accounts for approximately 0.9% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 26th biggest holding. Montrusco Bolton Investments Inc.’s holdings in Zoetis were worth $76,860,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nova Wealth Management Inc. acquired a new position in Zoetis in the first quarter valued at about $25,000. 1248 Management LLC acquired a new position in Zoetis in the first quarter valued at about $27,000. Saudi Central Bank acquired a new position in Zoetis in the first quarter valued at about $29,000. REAP Financial Group LLC grew its stake in Zoetis by 201.5% in the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after acquiring an additional 131 shares during the period. Finally, Cornerstone Planning Group LLC grew its stake in Zoetis by 79.3% in the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock valued at $30,000 after acquiring an additional 88 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ZTS has been the subject of a number of research analyst reports. Argus reissued a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Piper Sandler upped their price objective on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Zoetis has a consensus rating of “Hold” and an average target price of $196.71.

Zoetis Stock Down 1.6%

ZTS stock opened at $141.05 on Monday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market capitalization of $62.51 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.26 and a beta of 0.90. The business has a 50-day moving average of $149.24 and a 200-day moving average of $154.33. Zoetis Inc. has a fifty-two week low of $139.34 and a fifty-two week high of $196.55.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the company posted $1.56 earnings per share. Zoetis’s revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.